small molecule

RAYOS

PREDNISONE

Loss of exclusivityJanuary 2028latest FDA-listed patent expiry
CompanyHORIZON THERAPEUTICS USA INC

Drug detail

Brand nameRAYOS
Active ingredientPREDNISONE
Strength5MG
Dosage formTABLET, DELAYED RELEASE
RouteORAL
ModalitySmall molecule
FDA approvalJuly 2012
Marketing statusDISCN

Listed patents

PatentExpiresType
8168218January 2028product
9504699August 2027use U-1362

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the latest FDA-listed patent expiry; estimates are projections, not legal advice.

RAYOS patent cliff — loss of exclusivity January 2028 | CliffBio